Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells

Details for Australian Patent Application No. 2004288157 (hide)

Owner Oregon Health & Science University The United States of America as represented by the US Department of Veterans Affairs

Inventors Vandenbark, Arthur A.; Burrows, Gregory G.

Agent Griffith Hack

Pub. Number AU-B-2004288157

PCT Pub. Number WO2005/044982

Priority 60/500,660 05.09.03 US

Filing date 7 September 2004

Wipo publication date 19 May 2005

Acceptance publication date 17 March 2011

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/044982 Priority application(s): WO2005/044982

10 March 2011 Assignment before Grant

  Oregon Health & Science University The application has been assigned to Oregon Health & Science University; The United States of America as represented by the US Department of Veterans Affairs

17 March 2011 Application Accepted

  Published as AU-B-2004288157

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004288165-Modification of lubricant properties in an operating all loss lubricating system

2004288143-RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA)